Literature DB >> 20733137

Can the interim fluorodeoxyglucose-positron emission tomography standardized uptake value be used to determine the need for residual mass biopsy after dose-dense immunochemotherapy for advanced diffuse large B-cell lymphoma?

Malik E Juweid, Brian Smith, Emmanuel Itti, Michel Meignan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20733137     DOI： 10.1200/JCO.2010.30.4394

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  PET Molecular Imaging-Directed Biopsy: A Review.

Authors:  Baowei Fei; David M Schuster
Journal:  AJR Am J Roentgenol       Date:  2017-05-15       Impact factor: 3.959

2.  An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.

Authors:  Emmanuel Itti; Michel Meignan; Alina Berriolo-Riedinger; Alberto Biggi; Amanda F Cashen; Pierre Véra; Hervé Tilly; Barry A Siegel; Andrea Gallamini; René-Olivier Casasnovas; Corinne Haioun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-07       Impact factor: 9.236

3.  Core Needle Biopsy Targeting the Viable Area of Deep-Sited Dominant Lesion Verified by Color Doppler and/or Contrast-Enhanced Ultrasound Contribute to the Actionable Diagnosis of the Patients Suspicious of Lymphoma.

Authors:  Jian Li; Jing Han; Yu Wang; Yunxian Mo; Jibin Li; Jin Xiang; Zhiming Li; Jianhua Zhou; Siyu Wang
Journal:  Front Oncol       Date:  2020-10-07       Impact factor: 6.244

Review 4.  Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma.

Authors:  Deok-Hwan Yang; Sung-Hoon Jung; Jae-Sook Ahn; Yeo-Kyeoung Kim; Jung-Joon Min; Hee-Seung Bom; Je-Jung Lee; Hyeoung-Joon Kim
Journal:  Chonnam Med J       Date:  2015-12-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.